Action APGN APEXIGEN, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Autres langues Apexigen, Inc.

Actions

APGN

US03759B1026

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Apexigen, Inc.(NasdaqCM:APGN) dropped from S&P TMI Index
Pyxis Oncology Completes Acquisition of Apexigen
Apexigen, Inc.(NasdaqCM:APGN) dropped from NASDAQ Composite Index
Pyxis Oncology, Inc. completed the acquisition of Apexigen, Inc. from entities associated with Pfizer Inc., Lincoln Park Capital, LLC, managed by Laurion Capital Management LP, Bayer World Investments B.V. and others.
Apexigen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
APEXIGEN INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apexigen, Inc. - APGN
Apexigen Announces Phase 2 Data Evaluating Sotigalimab, its CD40 Agonist Antibody, in Combination with Doxorubicin in Patients with Advanced Soft Tissue Sarcoma Presented at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
Apexigen, Inc. Announces Phase 2 Data Evaluating Sotigalimab, its CD40 Agonist Antibody, in Combination with Doxorubicin in Patients with Advanced Soft Tissue Sarcoma Presented at the American Society of Clinical Oncology 2023 Annual Meeting
APEXIGEN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apexigen, Inc. - APGN
North American Morning Briefing : Nvidia Surge -2-
Shareholder Alert: Ademi LLP investigates whether Apexigen, Inc. has obtained a Fair Price in its transaction with Pyxis Oncology
Wall Street Set to Open Lower as Investors Await Progress on Debt-Ceiling Talks Ahead of Fed Minutes Release
Sector Update: Health Care Stocks Mixed Premarket Wednesday
Sector Update: Health Care
APGN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Apexigen, Inc. Is Fair to Shareholders
US Futures Lower as Investors Eye Debt Ceiling Talks, Await Fed Minutes Release
Top Premarket Gainers
Pyxis Oncology to Acquire Apexigen in $16 Million All-Stock Deal
Pyxis Oncology to Acquire Apexigen
Apexigen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action APGN
  4. Actualités Apexigen, Inc.
  5. Autres langues